Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $9,730 | 3 | 42.2% |
| Consulting Fee | $9,379 | 2 | 40.7% |
| Travel and Lodging | $2,980 | 5 | 12.9% |
| Food and Beverage | $961.06 | 14 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $12,120 | 7 | $0 (2019) |
| GENZYME CORPORATION | $9,029 | 11 | $0 (2019) |
| ModernaTX, Inc. | $1,490 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $135.98 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $88.77 | 1 | $0 (2018) |
| One Lambda, Inc. | $35.88 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.88 | 1 | One Lambda, Inc. ($35.88) |
| 2023 | $1,490 | 1 | ModernaTX, Inc. ($1,490) |
| 2022 | $135.98 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($135.98) |
| 2021 | $150.00 | 1 | Alexion Pharmaceuticals, Inc. ($150.00) |
| 2019 | $12,151 | 7 | CSL Behring ($12,040) |
| 2018 | $9,007 | 11 | GENZYME CORPORATION ($8,918) |
| 2017 | $80.20 | 1 | CSL Behring ($80.20) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.88 | General |
| 12/13/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,490.00 | General |
| 06/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $70.26 | General |
| 06/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $65.72 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 02/28/2019 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2019 | CSL Behring | — | Honoraria | Cash or cash equivalent | $3,510.00 | General |
| 02/20/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $1,325.47 | General |
| 02/20/2019 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $83.50 | General |
| 01/09/2019 | CSL Behring | — | Honoraria | Cash or cash equivalent | $6,070.00 | General |
| 01/09/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $966.95 | General |
| 01/09/2019 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $84.00 | General |
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Consulting Fee | Cash or cash equivalent | $7,889.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | In-kind items and services | $341.41 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Travel and Lodging | Cash or cash equivalent | $87.14 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $69.96 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2018 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $88.77 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2017 | CSL Behring | Product in Development (Biological) | Food and Beverage | In-kind items and services | $80.20 | General |
| Category: Product in Development | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 123 | 192 | $300,090 | $58,785 |
| 2022 | 6 | 169 | 262 | $399,390 | $77,631 |
| 2021 | 6 | 243 | 418 | $585,710 | $114,591 |
| 2020 | 6 | 156 | 356 | $341,625 | $68,284 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 20 | 20 | $240,000 | $46,942 | 19.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 88 | $14,080 | $4,268 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 39 | $11,310 | $3,264 | 28.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $7,560 | $1,758 | 23.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $4,640 | $1,293 | 27.9% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 15 | 15 | $22,500 | $1,259 | 5.6% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 26 | 26 | $312,000 | $61,811 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 61 | $17,690 | $5,077 | 28.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 43 | 109 | $17,440 | $4,042 | 23.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $14,040 | $3,603 | 25.7% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 22 | 22 | $33,000 | $1,782 | 5.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 18 | 18 | $5,220 | $1,315 | 25.2% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 38 | 38 | $456,000 | $92,191 | 20.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 63 | 217 | $34,720 | $7,619 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 61 | $17,690 | $5,237 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 36 | $19,440 | $4,498 | 23.1% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 32 | 32 | $48,000 | $2,722 | 5.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 34 | 34 | $9,860 | $2,324 | 23.6% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 21 | 21 | $252,000 | $51,242 | 20.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 44 | 236 | $37,760 | $8,641 | 22.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 23 | $12,420 | $2,940 | 23.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 31 | $8,990 | $2,127 | 23.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 29 | 29 | $6,455 | $2,030 | 31.5% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 16 | 16 | $24,000 | $1,304 | 5.4% |
About Dr. Ron Shapiro, MD
Dr. Ron Shapiro, MD is a Transplant Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720053911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ron Shapiro, MD has received a total of $23,050 in payments from pharmaceutical and medical device companies, with $35.88 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Honoraria" ($9,730).
As a Medicare-enrolled provider, Shapiro has provided services to 691 Medicare beneficiaries, totaling 1,228 services with total Medicare billing of $319,291. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Location New York, NY
- Active Since 02/21/2006
- Last Updated 02/17/2015
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1720053911
Products in Payments
- THYMOGLOBULIN (Drug) $9,118
- Soliris (Drug) $150.00
- Product in Development (Biological) $80.20
- LIVTENCITY (Drug) $65.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in New York
Mr. Myron Schwartz, M.d, M.D
Transplant Surgery — Payments: $48,120
Lewis Teperman, M.d, M.D
Transplant Surgery — Payments: $36,454
Sasan Roayaie, Md, MD
Transplant Surgery — Payments: $35,035
Dr. Lloyd Ratner, Md, MD
Transplant Surgery — Payments: $33,745
Parissa Tabrizian, Md, MD
Transplant Surgery — Payments: $25,119
Dr. Tomoaki Kato, Md, MD
Transplant Surgery — Payments: $16,680